Research on Acquired Immune Deficiency Syndrome, or AIDS, has advanced tremendously since the disease was first reported in 1981. Anti-retroviral drugs have allowed people living with AIDS enjoy longer and healthier lives. However, the development of an HIV vaccine continues to be a formidable challenge for scientists. Mark Feinberg, president and CEO of the International AIDS Vaccine Initiative (IAVI), who was in India recently, spoke to Ankur Paliwal about challenges in developing a vaccine, recent breakthroughs, and a rising anti-vaccine movement. Edited excerpts:
Why is it so challenging to make an AIDS vaccine?
Most of the available vaccines against